Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Valazyd 40 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Valazyd 40

Approved

STANDARD

Valazyd 40

Cadila Healthcare Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 8237ddd79a2fcb24
Company: Cadila Healthcare Ltd.
Type: Standard

Approval Details

Approval Id: 8237ddd79a2fcb24
Drug Approval Philippines Name: Valazyd 40
Product Name: Valazyd 40
Registration Number: DRP-7307
Brand Name: Valazyd 40
Generic Name: Valsartan
Dosage Form: Film Coated Tablet
Dosage Strength: 40 mg
Manufacturer: Cadila Healthcare Ltd.
Importer: Zydus Philippines, Inc.
Distributor: Zydus Philippines, Inc.
Company Detail Path: /organization/cadila-healthcare-ltd
Issuance Date: 25 January 2023
Expiry Date: 05 June 2028
Pharmacologic Category: Antihypertensive (Angiotensin-2-receptor blocker)
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

8237ddd79a2fcb24

Type

Standard

Back to Philippines FDA Approvals